Patients Experience 100 Percent Remission in Clinical Trial
A small clinical trial reported that 100 percent of the patients experienced remission of rectal cancer after immunotherapy.
By May 31, 2022, most health insurance plans will fully cover this procedure to evaluate a positive stool-based test for colon cancer. Check with your insurance about your coverage.Learn More
Our gastroenterologists and staff at Glendora Digestive Disease Institute are dedicated to providing quality, affordable care to the community in our quest to lower colon cancer rates and treat an array of digestive diseases, including Crohn’s Disease, irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD).
We believe in compassionate medicine, where patients feel reassured and unrushed. We hold ourselves to the highest of standards, as our center is accredited by the Accreditation Association for Ambulatory Health Care (AAAHC).
Our board-certified GI doctors specialize in a myriad of GI procedures, including colonoscopy, flexible sigmoidoscopy and upper endoscopy.
If you are due for a colonoscopy or in need of a GI procedure, don’t put it off any longer. Give us a call today!
A small clinical trial reported that 100 percent of the patients experienced remission of rectal cancer after immunotherapy.Read More
People who are overweight or obese may skip life-saving cancer screenings because they fear their doctor’s judgment.Read More
A new meta-analysis from Johns Hopkins School of Medicine suggests taller people may be more likely to develop colon cancer than shorter people.Read More